Presentation TCT 2025 TCT 117: Contemporary Trends in Mortality and Resource Utilization in Atrial Fibrillation Versus Non-Atrial Fibrillation in Transcatheter Aortic Valve Replacement: A National Study Presenter: Chaitanya Tumuluri October 26, 2025
Presentation TCT 2025 TCT 1408: Transcatheter Aortic Valve Replacement (TAVR) and the Left Main Challenge: Risk Stratification and Bailout Strategies Presenter: Enhua Wang October 26, 2025
Presentation TCT 2025 TCT 72: Outcomes of Transcatheter Aortic Valve Replacement in Cardiac Amyloidosis: A Propensity-Matched Multicenter Analysis Presenter: Vaidehi Mendpara October 26, 2025
Presentation TCT 2025 TCT 1407: Transcatheter Aortic Valve Replacement Prosthesis Selection: A Case of Annular and Sinotubular Junction Size Mismatch Presenter: Logan L. Vincent October 26, 2025
Presentation TCT 2025 TCT 73: Outcomes of Transcatheter Aortic Valve Replacement in Patients with Cardiac Amyloidosis: Impact of Disease Recognition and Treatment Response Presenter: Tamari Lomaia October 26, 2025
Presentation TCT 2025 TCT 885: Unique Flow Characteristics and Physiologic Vortex Integrity in Epygon Transcatheter Mitral Valve Replacement Presenter: Mohammad Sarraf October 26, 2025
Presentation TCT 2025 TCT 886: The CoApt Valve: A Novel Atrioventricular Valve Device by NeoCor Presenter: George A. Kramer October 26, 2025
Presentation TCT 2025 TCT 880: Mitral Annular Remodeling Following HighLife Transcatheter Mitral Valve Replacement: a Single-Center Experience Presenter: Wolfgang Rottbauer October 26, 2025
Presentation TCT 2025 TCT 881: Bench Testing of a purpose built semi-rigid, saddle shaped complete mitral annuloplasty ring designed to circularize and facilitate future transcatheter mitral valve-in-ring procedures Presenter: Keith B. Allen October 26, 2025
Presentation TCT 2025 TCT 1113: Transcatheter versus Surgical Aortic-Valve Replacement in Women with High versus Low Gradient Severe Aortic Stenosis: A Substudy of the RHEIA Trial Presenter: Philippe Pibarot October 26, 2025
Presentation TCT 2025 TCT 1932: Targeted Drugs, PADN, and Transcatheter Closure for Atrial Septal Defect-associated Pulmonary Hypertension: Case Series Presenter: Nanchao Hong October 26, 2025
Presentation TCT 2025 TCT 1456: Hepatic Vein Flow Reversal Secondary to Iatrogenic Atrial Septal Defect Following Transcatheter Mitral Valve-in-Valve Implantation Presenter: Parth S. Patel October 26, 2025
Presentation TCT 2025 TCT 882: Impact of Different Leaflet and Stent Materials on Bileaflet Bioprosthetic Mitral Valve Performance Presenter: Joseph Chibuike Nwokeafor October 26, 2025
Presentation TCT 2025 CT Imaging for Transcatheter Tricuspid Valve Replacement: Matching Anatomy With Device Features Presenter: Omar K. Khalique October 26, 2025
Presentation TCT 2025 TCT 879: Left Ventricular Reverse Remodeling Following Transcatheter Mitral Valve Replacement With The HighLife System Presenter: Thomas E. Waggoner October 26, 2025
Presentation TCT 2025 TCT 1110: Transcatheter Versus Surgical Aortic-Valve Replacement in Pulmonary-Hypertension Patients: A Systematic Review and Meta-analysis Presenter: Daniel Leal October 26, 2025
Presentation TCT 2025 TCT 878: Monocentric experience with the HighLife and HighLife Clarity TransSeptal Mitral Valve Replacement systems in the context of contemporary transcatheter mitral valve replacement systems Presenter: Wolfgang Rottbauer October 26, 2025
Presentation TCT 2025 TCT 1108: Contemporary Structural Therapy for Severe Pure Aortic Regurgitation: Dedicated Transcatheter Aortic Valve Replacement versus Sternum-Sparing Mini Surgical Aortic Valve Replacement Presenter: Axel Unbehaun October 26, 2025
Presentation TCT 2025 TCT 883: Long-term (three-year) Clinical Outcomes and Valve Performance After HighLife TMVR Presenter: Wolfgang Rottbauer October 26, 2025
News Conference News TCT 2025 TTVR Remains Safe, Effective in Presence of CIED Leads Todd Neale October 25, 2025